Inhibitex amends IPO

Inhibitex (Atlanta, Ga.) amended its proposed IPO and now hopes to sell 5.9 million shares at $10-$12 through Thomas Weisel; Lazard; and Harris Nesbitt. In the company's amended filing, Nesbitt was ad...